NCT04105582View on ClinicalTrials.gov

Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

February 1, 2022

Conditions
Breast CancerTriple Negative Breast Cancer
Interventions
BIOLOGICAL

Neo-antigen pulsed Dendritic cell

Patients that have already finished their conventional treatment (chemotherapy and/or surgery) will be vaccinated with dendritic cells pulsed with synthetic peptide

Trial Locations (1)

111321

Universidad Nacional de Colombia, Bogota

All Listed Sponsors
collaborator

Fundación Salud de los Andes

OTHER

lead

Universidad Nacional de Colombia

OTHER

NCT04105582 - Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells | Biotech Hunter | Biotech Hunter